Foresite Capital Management III’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-356,492
| Closed | -$4.81M | – | 9 |
|
|
2020
Q1 | $4.81M | Sell |
356,492
-1,993,985
| -85% | -$26.9M | 7.66% | 6 |
|
|
2019
Q4 | $56.8M | Hold |
2,350,477
| – | – | 31.84% | 1 |
|
|
2019
Q3 | $45.2M | Buy |
2,350,477
+400,000
| +21% | +$7.69M | 17.25% | 1 |
|
|
2019
Q2 | $57.6M | Hold |
1,950,477
| – | – | 18.9% | 1 |
|
|
2019
Q1 | $92.6M | Hold |
1,950,477
| – | – | 24.12% | 1 |
|
|
2018
Q4 | $70.4M | Buy |
1,950,477
+242,431
| +14% | +$8.75M | 23.13% | 1 |
|
|
2018
Q3 | $105M | Hold |
1,708,046
| – | – | 23.2% | 1 |
|
|
2018
Q2 | $115M | Sell |
1,708,046
-242,431
| -12% | -$16.4M | 24.85% | 1 |
|
|
2018
Q1 | $106M | Hold |
1,950,477
| – | – | 23.06% | 1 |
|
|
2017
Q4 | $117M | Hold |
1,950,477
| – | – | 32.7% | 1 |
|
|
2017
Q3 | $94.8M | Hold |
1,950,477
| – | – | 26.11% | 1 |
|
|
2017
Q2 | $102M | Buy |
1,950,477
+353,776
| +22% | +$18.6M | 33.48% | 1 |
|
|
2017
Q1 | $72.4M | Sell |
1,596,701
-1,751
| -0.1% | -$79.4K | 27.79% | 1 |
|
|
2016
Q4 | $60.5M | Sell |
1,598,452
-99,432
| -6% | -$3.76M | 26.29% | 1 |
|
|
2016
Q3 | $64.1M | Buy |
1,697,884
+352,571
| +26% | +$13.3M | 29.95% | 1 |
|
|
2016
Q2 | $23.7M | Buy |
1,345,313
+388,187
| +41% | +$6.83M | 16.25% | 2 |
|
|
2016
Q1 | $11.6M | Buy |
957,126
+724,369
| +311% | +$8.81M | 9.01% | 3 |
|
|
2015
Q4 | $5.67M | Buy |
+232,757
| New | +$5.67M | 5.03% | 8 |
|